Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 17, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The DREAM Cohort study is looking at how exposure to environmental chemicals and pollutants during pregnancy might affect cancer risks for both mothers and their children. Researchers want to understand how these harmful substances can impact health, especially since pregnancy can make women more sensitive to these toxins. This study will involve a diverse group of pregnant women and will follow them and their children over time to gather important information.
To participate in this study, you need to be a pregnant woman over 18 years old who speaks either English or Spanish. If you join, your child will also be included in the study after they are born. The research team will provide more information about what being part of the study involves, and they are currently looking for participants. It's a great opportunity to contribute to important research that could help improve health outcomes for future generations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women, over the age of 18 years.
- • English or Spanish-speaking.
- • Children born of participants enrolled during pregnancy will be enrolled in the DREAM cohort.
- • Inclusion criterion for the DREAM Cohort Ambassador Program is limited to research participants in the DREAM Cohort.
- Exclusion Criteria:
- • Women under the age of 18.
- • Women expecting the birth of multiples (twins, triplets, etc.).
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Berkeley, California, United States
Fresno, California, United States
Patients applied
Trial Officials
Peggy Reynolds, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials